Effects of Extracorporeal Shockwave Therapy on Tendinopathies: A Systematic Literature Review

体外冲击波疗法 医学 体外冲击波疗法 肌腱病 体外 系统回顾 重症监护医学
作者
Rodiel Kirby Baloy,Oscar Chen
出处
期刊:Archives of Physical Medicine and Rehabilitation [Elsevier BV]
卷期号:103 (3): e5-e5
标识
DOI:10.1016/j.apmr.2022.01.013
摘要

Objective(s)

This literature review aims to look at the state of evidence among previous systematic reviews and randomized controlled trials examining the effects of ESWT on tendinopathies of the upper and lower limbs.

Data Sources

Systematic literature between 2011-2021 in the databases of PubMed, PEDro Database, Ovid, CINAHL, Cochrane, EBSCO between May 3 to 15, 2021.

Study Selection

Criteria for: randomized controlled trials - full text available, PEDro score > 6, and conducted in the past 10 years systematic reviews - full text available, inclusion criteria available, with both pain and functional outcome measures, and conducted in the past 10 years

Data Extraction

Eight randomized controlled trials with a total of 452 subjects met quality guidelines using the PEDro scale. 12 systematic reviews with a total of 12,063 subjects met methodological guidelines.

Data Synthesis

249 articles were screened, and 20 studies with a total population of n = 12,515 were included. With heterogeneity in frequency, dosage, and volume no meta-analysis was conducted. There were statistically significant improvements reported in terms of pain and function with ESWT on tendinopathies in 14 studies (n= 8,537). On the other hand, no clinically significant differences were found in the use of ESWT in 3 studies (n=829), and no effects were found in 2 studies (n= 3,149).

Conclusions

The results suggest that in the management of tendinopathies, the use of ESWT has a clinically significant effect on pain and functional outcomes. In conclusion, a review of current randomized controlled trials and systematic reviews presented evidence for ESWT for tendinopathies. While the use of ESWT may improve pain and functional outcome, further studies towards dosing and prescription is suggested.

Author(s) Disclosures

Dr. Baloy has no relevant financial or nonfinancial relationships to disclose. Mr. Chen has no relevant financial or nonfinancial relationships to disclose.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
2秒前
xyysee完成签到,获得积分10
2秒前
hansJAMA发布了新的文献求助10
4秒前
xin发布了新的文献求助10
4秒前
xinjie发布了新的文献求助10
6秒前
晨光中完成签到,获得积分10
7秒前
大模型应助研友_LjDyNZ采纳,获得10
7秒前
稳赚赚完成签到,获得积分10
7秒前
7秒前
斯文的莞给斯文的莞的求助进行了留言
8秒前
cdercder应助kdjm688采纳,获得10
9秒前
10秒前
13秒前
传奇3应助一个小太阳鸭采纳,获得10
14秒前
123321完成签到 ,获得积分10
14秒前
15秒前
18秒前
科研通AI5应助hansJAMA采纳,获得10
19秒前
完美世界应助姽婳wy采纳,获得10
21秒前
Solarenergy发布了新的文献求助10
22秒前
jia完成签到 ,获得积分10
23秒前
23秒前
现实的俊驰完成签到 ,获得积分10
25秒前
25秒前
不是一个名字完成签到,获得积分10
28秒前
Leofar完成签到 ,获得积分10
29秒前
脑洞疼应助科研通管家采纳,获得10
29秒前
科目三应助科研通管家采纳,获得10
29秒前
HOME发布了新的文献求助10
29秒前
Ava应助科研通管家采纳,获得10
30秒前
慕青应助科研通管家采纳,获得10
30秒前
Hello应助科研通管家采纳,获得10
30秒前
大模型应助科研通管家采纳,获得10
30秒前
小蘑菇应助科研通管家采纳,获得10
30秒前
故酒应助科研通管家采纳,获得10
30秒前
故酒应助科研通管家采纳,获得10
30秒前
30秒前
天天快乐应助科研通管家采纳,获得10
30秒前
李健应助科研通管家采纳,获得10
30秒前
高分求助中
【此为提示信息,请勿应助】请按要求发布求助,避免被关 20000
ISCN 2024 – An International System for Human Cytogenomic Nomenclature (2024) 3000
Continuum Thermodynamics and Material Modelling 2000
Encyclopedia of Geology (2nd Edition) 2000
105th Edition CRC Handbook of Chemistry and Physics 1600
Maneuvering of a Damaged Navy Combatant 650
Mindfulness and Character Strengths: A Practitioner's Guide to MBSP 380
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3776299
求助须知:如何正确求助?哪些是违规求助? 3321743
关于积分的说明 10207616
捐赠科研通 3037087
什么是DOI,文献DOI怎么找? 1666533
邀请新用户注册赠送积分活动 797544
科研通“疑难数据库(出版商)”最低求助积分说明 757870